When should transplant physicians think about familial blood cancers?-Reference-Cited by-同舟云学术

When should transplant physicians think about familial blood cancers?

Published:2019-06-18 Issue:4 Volume:2 Page:
ISSN:2573-8461
Container-title:ADVANCES IN CELL AND GENE THERAPY
language:en
Short-container-title:Adv Cell Gene Ther

Author:

Trottier Amy M.¹^ORCID,Bannon Sarah²,Bashir Qaiser³,Carraway Hetty E.⁴,Hofmann Inga⁵,Godley Lucy A.¹⁶

Affiliation:

1. Section of Hematology/Oncology, Department of Medicine and The University of Chicago Comprehensive Cancer Center, The University of Chicago Chicago Illinois

2. Department of Clinical Cancer Genetics The University of Texas MD Anderson Cancer Center Houston Texas

3. Department of Stem Cell Transplantation & Cellular Therapy The University of Texas MD Anderson Cancer Center Houston Texas

4. Leukemia Program, Taussig Cancer Institute, Cleveland Clinic Cleveland Ohio

5. Division of Hematology, Oncology, Bone Marrow Transplantation, Department of Pediatrics, American Family Children’s Hospital University of Wisconsin Madison Wisconsin

6. Department of Human Genetics The University of Chicago Chicago Illinois

Publisher

Hindawi Limited

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acg2.68

Reference65 articles.

1. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia

2. SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7

3. Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms

4. GATA2 deficiency and related myeloid neoplasms

5. Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematopoietic Cell Transplantation in Adult With Acute Myeloid Leukemia;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024

2. Familial Myeloid Neoplasms—When to Suspect and What to Do?;Cancer Consult;2023-11-18

3. Hereditary hematologic malignancies: a Canadian perspective;Canadian Hematology Today;2022-11-01

4. Cord blood transplants supported by unrelated donor CD34+ progenitor cells;Bone Marrow Transplantation;2020-06-09